CRESTOR

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 422000
                    [Title] => Breakthrough study shows rosuvastatin prolongs lives
                    [Summary] => 
I  have known UP-PGH graduate Dr. Emman Arca for a long time, and I knew he was part of AstraZeneca’s Medical Affairs team. Four years ago, I remember discussing with Dr. Arca a statin drug given for cholesterol problems, rosuvastatin.
                    [DatePublished] => 2008-12-09 00:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 63152
                    [Title] => Can rosuvastatin save the world?
                    [Summary] => 
Ever since I was young, I have always loved astronomy. I would memorize all the nine planets, the names of their moons, their distance from the earth, and other peculiar details. My vocabulary was filled with words like meteor, asteroid, comet, and universe.
                    [DatePublished] => 2008-05-20 00:00:00
                    [ColumnID] => 134789
                    [Focus] => 0
                    [AuthorID] => 1805275
                    [AuthorName] => Dr. Willie T. Ong
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 388396
                    [Title] => New drug greatly improves cholesterol levels
                    [Summary] => 



A powerful new drug can significantly improve cholesterol levels in patients highly prone to heart attacks, results of a worldwide clinical study showed.


Based on the findings of ASTEROID (A Study to Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden), intensive therapy with the drug rosuvastatin could block the build-up of fatty deposits inside the arteries — a condition known as coronary atherosclerosis — which can trigger cardiovascular disease.


                    [DatePublished] => 2007-03-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1237712
                    [AuthorName] => Conrado Diaz Jr.
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Breakthrough study shows rosuvastatin prolongs lives

By Dr. Willie T. Ong | December 9, 2008 - 12:00am

I  have known UP-PGH graduate Dr. Emman Arca for a long time, and I knew he was part of AstraZeneca’s Medical Affairs team. Four years ago, I remember discussing with Dr. Arca a statin drug given for cholesterol...

Health And Family

Can rosuvastatin save the world?

By Dr. Willie T. Ong | May 20, 2008 - 12:00am

Ever since I was young, I have always loved astronomy. I would memorize all the nine planets, the names of their moons, their distance from the earth, and other peculiar details. My vocabulary was filled with words...

Health And Family

New drug greatly improves cholesterol levels

By Conrado Diaz Jr. | March 8, 2007 - 12:00am

A powerful new drug can significantly improve cholesterol levels in patients highly prone to heart attacks, results of a worldwide clinical study showed. Based on the findings of ASTEROID (A Study to Evaluate...

Science and Environment